These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2998181)

  • 21. The non-effect of pirenzepine in dietary resistant irritable bowel syndrome.
    Gilvarry J; Kenny A; Fielding JF
    Ir J Med Sci; 1989 Oct; 158(10):262. PubMed ID: 2559903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of dietary fiber on symptoms and rectosigmoid motility in patients with irritable bowel syndrome. A controlled, crossover study.
    Cook IJ; Irvine EJ; Campbell D; Shannon S; Reddy SN; Collins SM
    Gastroenterology; 1990 Jan; 98(1):66-72. PubMed ID: 2152777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Irritable bowel syndrome and lactose maldigestion in recurrent abdominal pain in childhood.
    Gremse DA; Nguyenduc GH; Sacks AI; DiPalma JA
    South Med J; 1999 Aug; 92(8):778-81. PubMed ID: 10456715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of a Chinese Herbal Medicine in Providing Adequate Relief of Constipation-predominant Irritable Bowel Syndrome: A Randomized Controlled Trial.
    Bensoussan A; Kellow JE; Bourchier SJ; Fahey P; Shim L; Malcolm A; Boyce P
    Clin Gastroenterol Hepatol; 2015 Nov; 13(11):1946-54.e1. PubMed ID: 26133902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological interventions for recurrent abdominal pain (RAP) in childhood.
    Huertas-Ceballos A; Macarthur C; Logan S
    Cochrane Database Syst Rev; 2002; (1):CD003017. PubMed ID: 11869650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of recurrent abdominal pain: components analysis of four treatment protocols.
    Humphreys PA; Gevirtz RN
    J Pediatr Gastroenterol Nutr; 2000 Jul; 31(1):47-51. PubMed ID: 10896070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized, double-blind, placebo-controlled, two-period crossover clinical trial of psyllium fiber in children with hypercholesterolemia.
    Dennison BA; Levine DM
    J Pediatr; 1993 Jul; 123(1):24-9. PubMed ID: 8391569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methodological challenges to treatment trials for recurrent abdominal pain in children.
    Ball TM; Weydert JA
    Arch Pediatr Adolesc Med; 2003 Nov; 157(11):1121-7. PubMed ID: 14609904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
    Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Domperidone treatment in the irritable bowel syndrome.
    Fielding JF
    Digestion; 1982; 23(2):125-7. PubMed ID: 6284574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on the Management of Diarrhea-Predominant Irritable Bowel Syndrome: Focus on Rifaximin and Eluxadoline.
    Rivkin A; Rybalov S
    Pharmacotherapy; 2016 Mar; 36(3):300-16. PubMed ID: 26971716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled pilot clinical study.
    Majeed M; Nagabhushanam K; Natarajan S; Sivakumar A; Ali F; Pande A; Majeed S; Karri SK
    Nutr J; 2016 Feb; 15():21. PubMed ID: 26922379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of synbiotic fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis ssp. lactis BB-12 on the fecal microbiota of adults with irritable bowel syndrome: A randomized double-blind, placebo-controlled trial.
    Bogovič Matijašić B; Obermajer T; Lipoglavšek L; Sernel T; Locatelli I; Kos M; Šmid A; Rogelj I
    J Dairy Sci; 2016 Jul; 99(7):5008-5021. PubMed ID: 27157575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome.
    Quartero AO; Meineche-Schmidt V; Muris J; Rubin G; de Wit N
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003460. PubMed ID: 15846668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osmotic and stimulant laxatives for the management of childhood constipation.
    Gordon M; Naidoo K; Akobeng AK; Thomas AG
    Cochrane Database Syst Rev; 2012 Jul; (7):CD009118. PubMed ID: 22786523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Irritable bowel syndrome in children].
    Ohta T; Shindo T; Kojima K
    Nihon Rinsho; 1992 Nov; 50(11):2724-8. PubMed ID: 1287248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of a high-fiber diet on symptoms of irritable bowel syndrome: a randomized clinical trial.
    Aller R; de Luis DA; Izaola O; la Calle F; del Olmo L; Fernandez L; Arranz T; González Hernandez JM
    Nutrition; 2004 Sep; 20(9):735-7. PubMed ID: 15325678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of fiber supplementation on irritable bowel syndrome: a systematic review and meta-analysis.
    Moayyedi P; Quigley EM; Lacy BE; Lembo AJ; Saito YA; Schiller LR; Soffer EE; Spiegel BM; Ford AC
    Am J Gastroenterol; 2014 Sep; 109(9):1367-74. PubMed ID: 25070054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of ispaghula husk in the management of irritable bowel syndrome (a randomized double-blind crossover study).
    Golechha AC; Chadda VS; Chadda S; Sharma SK; Mishra SN
    J Assoc Physicians India; 1982 Jun; 30(6):353-5. PubMed ID: 6302072
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of fiber supplementation in the treatment of irritable bowel syndrome: a systematic review and meta-analysis.
    Nagarajan N; Morden A; Bischof D; King EA; Kosztowski M; Wick EC; Stein EM
    Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1002-10. PubMed ID: 26148247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.